UV Dosimetry Feedback in NMSC Patients

Non-Melanoma Skin Cancer Clinical Trial

Official title:

UV Dosimetry Feedback in Non-Melanoma Skin Cancer Patients

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03757663
• Other study ID #: 17-2134.cc
• Status: Withdrawn
• Phase: N/A
• Start date: March 12, 2018
• Est. completion date: August 30, 2019

Study information

• Verified date: September 2019
• Source: University of Colorado, Denver
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to characterize UV exposures among NMSC patients (those with a history of skin cancer) and to pilot an innovative behavioral intervention to decrease modifiable UV exposures. It will use UV dosimeters to objectively measure UV exposure and provide time and activity specific UV data on an individual level. These data will be used to develop a targeted and personalized behavioral feedback plan with counseling aimed at effective sun exposure behavior change

Description:

The study will focus on helping to prevent NMSC and its associated morbidity through learning when patients are unintentionally exposed to extreme UV radiation. It will then help to create manageable and realistic behavioral interventions to reduce exposure, while also educating patients of the dangers of abundant sun exposure.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: August 30, 2019
• Est. primary completion date: August 30, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• Patients between ages 18 and 50.

• Must be diagnosed with non-melanoma skin cancer.

Exclusion Criteria:

• Patients, who at the discretion of the clinician, are too ill or sick.

• Non-English speaking patients.

Related Conditions & MeSH terms

• Non-Melanoma Skin Cancer
• Skin Neoplasms

Intervention

Behavioral:
• UV Counseling
Participants will self-report their knowledge and attitudes related to UV exposure. They will then wear a dosimeter for 3 weeks. After, the study team will counsel the participants on their UV levels and exposure, creating a personal plan and advice for avoiding sun exposure before letting the participants wear the dosimeter for an additional 3 weeks.

Locations

Country	Name	City	State
United States	University of Colorado	Aurora	Colorado

Sponsors (1)

Lead Sponsor	Collaborator
University of Colorado, Denver

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Identify Discrepancies of Self-Reported Sun Exposure and Actual Sun Exposure	Measured using individual dosimeters and comparing it to what participants state they believe their level of sun exposure is	Start of study to end of study, up to 3 months
Primary	Identify Discrepancies of Self-Reported Sun Exposure and Actual Sun Exposure	Compare specific sun exposure behaviors responsible for the level of exposure versus what could be done to lessen it	Start of study to end of study, up to 3 months
Secondary	Behavioral Intervention and immediate follow-up	Participants will receive a personalized feedback plan and the success of the plan will be measured through individual dosimetry. We will track real time change in sun exposure based on repeat UV dosimetry.	Start of study to end of study, up to 3 months
Secondary	Long Term Follow Up - longitudinal change in sun exposure based on dosimetry	Track the longitudinal change in sun exposure comparing baseline UV dosimetry measurements to 3 month follow up dosimetry measurements to determine if the changes observed in outcome 3 are maintained.	Start of study to end of study, up to 3 months